Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 335
ORIGINAL ARTICLE
Year : 2011  |  Volume : 3  |  Issue : 5  |  Page : 227-233

E-Cadherin as a diagnostic biomarker in breast cancer


1 Department of Biochemistry, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, India
2 Department of General Surgery, Seth G. S. Medical College and K.E.M. Hospital, Parel, Mumbai, India
3 Department of General Surgery, Grant Medical College and Sir J. J. Group of Hospitals, Mumbai, India
4 Department of General Surgery, Government Medical College, Miraj, Maharashtra, India

Correspondence Address:
Rajeev Singhai
C-505, Beach Classic CHS Ltd, Near Gorai Pumping Station, Chikoowadi, Borivali (W), Mumbai-400092
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 22558599

Rights and PermissionsRights and Permissions

Background: E-cadherin is expressed in most normal epithelial tissues. Selective loss of E-cadherin can cause dedifferentiation and invasiveness in human carcinomas, leading E-cadherin to be classified as a tumor suppressor. Loss of E-cadherin has been demonstrated in invasive lobular carcinoma of the breast, but the relationship between E-cadherin expression and breast cancer histopathology and prognosis is less clear. Aim: Our objective was to assess loss of E-cadherin as a diagnostic breast cancer biomarker and as an aid to the sub-classification of invasive breast cancer. We also correlated the loss of expression of E-cadherin with various clinical and pathologic prognostic factors. Material and Methods: Breast cancer specimens after modified radical mastectomy were obtained from women who underwent surgery at Grant Medical College and Sir J.J Group of Hospitals, Mumbai, India between May 2007 and October 2010. We stained 276 breast cancers specimens with monoclonal antibodies to E-cadherin. The breast cancers were classified by histopathological type. Results: A statistical correlation of E-cadherin loss with a positive diagnosis of invasive lobular carcinoma was found, but there was no correlation with any prognostic tumor variables. A negative E-cadherin stain was a sensitive and specific biomarker to confirm the diagnosis of invasive lobular carcinoma (specificity 97.7%; negative predictive value 96.8%; sensitivity 88.1%; and positive predictive value 91.2%). Positive E-cadherin expression was also associated with tubulolobular carcinomas. Conclusions: E-cadherin immunohistochemistry is helpful in classifying breast cancer cases with indeterminate histopathologic features. E-cadherin loss is uncommon in non-lobular carcinomas but shows no correlation to currently established prognostic variables.


[FULL TEXT] [PDF Not available]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3069    
    Printed159    
    Emailed0    
    PDF Downloaded265    
    Comments [Add]    
    Cited by others 8    

Recommend this journal